Galvez, Janaya M.

HRN: 20-22-92  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2023
CEFTRIAXONE 1G (VIAL)
03/10/2023
03/16/2023
IV
660mg
OD
Pcap C
Waiting Final Action 
03/12/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/12/2023
03/19/2023
IV
660mg
Q6hours
PCAP-D
Waiting Final Action 
03/13/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/13/2023
03/19/2023
IV
100 Mg
OD
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: